SIVB : Summary for SVB Financial Group - Yahoo Finance

U.S. Markets close in 5 hrs 55 mins

SVB Financial Group (SIVB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
170.41-6.18 (-3.50%)
As of 10:05AM EST. Market open.
People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close176.59
Bid169.76 x 100
Ask170.53 x 100
Day's Range169.20 - 174.76
52 Week Range77.87 - 180.48
Avg. Volume546,880
Market Cap8.88B
PE Ratio (TTM)24.00
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals45 minutes ago

    Service platform OrderGroove clinches funding from National Securities

    New York-area startups and venture capitalists are making funding deals with the hopes of creating the next profitable company. Who gets: OrderGroove, a commerce platform and network used by brands to interact with consumers, has secured a new round of funding. Who invests: National Securities Corp. (NHLD) — whose portfolio companies include ride-sharing service Lyft and New York software company Palantir Technologies — led the effort.

  • PR Newswire5 days ago

    SVB Financial Group Confirms Date And Time Of Quarterly Earnings Call

    SANTA CLARA, Calif., Jan. 12, 2017 /PRNewswire/ -- SVB Financial Group (NASDAQ: SIVB) will report its financial results for the quarter and year ended December 31, 2016, on Thursday, January 26, 2017, ...

  • American City Business Journals8 days ago

    Endotronix raises $12M for wireless heart monitor

    Endotronix, a Woodridge, Illinois-based health tech company that helps patients monitor their heart condition, has raised $12 million in debt financing from Silicon Valley Bank. The company has built an implantable wireless pulmonary artery sensor and a cloud-based disease management data system, and it allows patients with advanced heart failure to measure their heart pressure each day via a handheld device. The company said the debt financing will be used to support the clinical program of its Cordella Heart Failure System.